---
title: "执行董事陈文远减持新意网集团 30 万股 每股作价约 6.31 港元"
description: "香港联交所最新资料显示，5 月 12 日，执行董事陈文远减持新意网集团 30 万股，每股作价 6.3123 港元，总金额约为 189.37 万港元。增持后最新持股数目为 341.2 万股，最新持股比例为 0.14%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/240521300.md"
published_at: "2025-05-16T07:40:02.000Z"
---

# 执行董事陈文远减持新意网集团 30 万股 每股作价约 6.31 港元

> 香港联交所最新资料显示，5 月 12 日，执行董事陈文远减持新意网集团 30 万股，每股作价 6.3123 港元，总金额约为 189.37 万港元。增持后最新持股数目为 341.2 万股，最新持股比例为 0.14%。

智通财经 APP 获悉，香港联交所最新资料显示，5 月 12 日，执行董事陈文远减持新意网集团 (01686) 30 万股，每股作价 6.3123 港元，总金额约为 189.37 万港元。增持后最新持股数目为 341.2 万股，最新持股比例为 0.14%。

### Related Stocks

- [01686.HK - 新意网集团](https://longbridge.com/zh-CN/quote/01686.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Standard Chartered PLC (OTCMKTS:SCBFF) Sees Significant Growth in Short Interest | Standard Chartered PLC (OTCMKTS:SCBFF) experienced a significant increase in short interest, rising 21.1% to 210,583 sha | [Link](https://longbridge.com/zh-CN/news/276119010.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-CN/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-CN/news/276035104.md) |
| UBS Remains a Buy on Netease Inc (9999) | UBS analyst maintained a Buy rating on Netease Inc yesterday and set a price target of HK$280.80.Valentine's Day Sale -  | [Link](https://longbridge.com/zh-CN/news/275830949.md) |
| Italy says it stands ready to train police in Gaza | Italy's Foreign Minister Antonio Tajani announced the country's readiness to train police forces in Gaza and the Palesti | [Link](https://longbridge.com/zh-CN/news/276056959.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。